Nadia P. Ewing

1.1k total citations
26 papers, 434 citations indexed

About

Nadia P. Ewing is a scholar working on Hematology, Genetics and Genetics. According to data from OpenAlex, Nadia P. Ewing has authored 26 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 10 papers in Genetics and 4 papers in Genetics. Recurrent topics in Nadia P. Ewing's work include Hemophilia Treatment and Research (19 papers), Platelet Disorders and Treatments (11 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Nadia P. Ewing is often cited by papers focused on Hemophilia Treatment and Research (19 papers), Platelet Disorders and Treatments (11 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Nadia P. Ewing collaborates with scholars based in United States, Italy and Canada. Nadia P. Ewing's co-authors include Carol K. Kasper, Cindy Leissinger, Leonard A. Valentino, David L. Becton, Darleen Powars, A. Gringeri, Erik Berntorp, C. Escuriola‐Ettingshausen, W. Kreuz and Paula K. Groncy and has published in prestigious journals such as JAMA, Blood and American Journal of Public Health.

In The Last Decade

Nadia P. Ewing

25 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadia P. Ewing United States 12 373 182 31 21 21 26 434
V. Garipidou Greece 11 197 0.5× 111 0.6× 30 1.0× 6 0.3× 34 1.6× 17 314
M. Rodet France 10 300 0.8× 123 0.7× 86 2.8× 15 0.7× 16 0.8× 15 369
Abdullah Al Jefri Saudi Arabia 9 291 0.8× 288 1.6× 15 0.5× 77 3.7× 15 0.7× 18 377
M Kuentz France 8 186 0.5× 82 0.5× 19 0.6× 22 1.0× 96 4.6× 13 260
G. Zeile Germany 5 366 1.0× 73 0.4× 105 3.4× 13 0.6× 18 0.9× 6 410
Laure Joseph France 8 157 0.4× 195 1.1× 42 1.4× 46 2.2× 7 0.3× 29 249
Astrid Haack Germany 4 314 0.8× 76 0.4× 80 2.6× 13 0.6× 32 1.5× 5 369
F D'Adamo Italy 9 202 0.5× 114 0.6× 129 4.2× 63 3.0× 28 1.3× 11 319
Nadira Azzi Belgium 8 91 0.2× 137 0.8× 35 1.1× 80 3.8× 37 1.8× 12 249
JP Vannier France 5 71 0.2× 97 0.5× 24 0.8× 48 2.3× 22 1.0× 10 199

Countries citing papers authored by Nadia P. Ewing

Since Specialization
Citations

This map shows the geographic impact of Nadia P. Ewing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia P. Ewing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia P. Ewing more than expected).

Fields of papers citing papers by Nadia P. Ewing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia P. Ewing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia P. Ewing. The network helps show where Nadia P. Ewing may publish in the future.

Co-authorship network of co-authors of Nadia P. Ewing

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia P. Ewing. A scholar is included among the top collaborators of Nadia P. Ewing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia P. Ewing. Nadia P. Ewing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soltis, Anthony R., Gauthaman Sukumar, Christoph Königs, et al.. (2020). Hemophilia A Inhibitor Subjects Show Unique PBMC Gene Expression Profiles That Include Up-Regulated Innate Immune Modulators. Frontiers in Immunology. 11. 1219–1219. 4 indexed citations
3.
Hockenberry, Marilyn, et al.. (2015). Venous Thromboembolism Risk Assessment and Prophylaxis Use in Pediatric, Adolescent, and Young Adult Hematology Oncology Patients. Journal of Pediatric Hematology/Oncology. Publish Ahead of Print(6). 455–8. 5 indexed citations
5.
Gringeri, A., Frederick A. Ofosu, Salvador Grancha, et al.. (2011). Understanding FVIII/VWF complex – report from a symposium of XXIX WFH meeting 2010. Haemophilia. 18(3). 469–475. 8 indexed citations
6.
Kaveri, Srini V., Pier Mannuccio Mannucci, Margaret Kurth, et al.. (2010). von Willebrand factor: what is its role in the immune response in haemophilia?. Haemophilia. 17(1). e235–8. 3 indexed citations
7.
Berntorp, Erik, Claire Collins, Roseline d’Oiron, et al.. (2010). Identifying non‐responsive bleeding episodes in patients with haemophilia and inhibitors: a consensus definition. Haemophilia. 17(1). e202–10. 17 indexed citations
8.
Valentino, Leonard A., Manuel Carção, Prasad Mathew, et al.. (2009). The application of bypassing‐agent prophylaxis in haemophilia A patients with inhibitors: a meeting report. Haemophilia. 15(4). 959–965. 11 indexed citations
9.
Valentino, Leonard A., Michael Recht, Amy D. Shapiro, et al.. (2009). Experience with a third generation recombinant factor VIII concentrate (Advate®) for immune tolerance induction in patients with haemophilia A. Haemophilia. 15(3). 718–726. 19 indexed citations
10.
Leissinger, Cindy, David L. Becton, Nadia P. Ewing, & Leonard A. Valentino. (2007). Prophylactic treatment with activated prothrombin complex concentrate (FEIBA®) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors. Haemophilia. 13(3). 249–255. 48 indexed citations
12.
Yuan, Shuai, et al.. (2007). Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.. PubMed. 23(2). 75–80. 3 indexed citations
14.
Kulkarni, Roshni, Louis M. Aledort, Erik Berntorp, et al.. (2002). Therapeutic choices for patients with hemophilia and high‐titer inhibitors. American Journal of Hematology. 69(2). 155–156. 1 indexed citations
15.
Kulkarni, Roshni, Erik Berntorp, Deborah Brown, et al.. (2001). Therapeutic choices for patients with hemophilia and high‐titer inhibitors. American Journal of Hematology. 67(4). 240–246. 46 indexed citations
16.
Goldsmith, Lowell A., Renata Polakowska, Anne R. Haake, et al.. (1993). Exclusion of candidate genes in Darier's disease using positional cloning. Journal of Dermatological Science. 6(1). 83–83. 1 indexed citations
17.
Schwartz, Richard S., et al.. (1989). Comparative efficacy of nonheated and heat‐treated factor IX complex concentrate in treatment of hemophiliacs with inhibitors. American Journal of Hematology. 30(1). 22–26. 1 indexed citations
18.
Ewing, Nadia P.. (1988). Induction of Immune Tolerance to Factor VIII in Hemophiliacs With Inhibitors. JAMA. 259(1). 65–65. 89 indexed citations
19.
Meyer, Paul R., Robert L. Modlin, Darleen Powars, et al.. (1983). Altered distribution of T-lymphocyte subpopulations in lymph nodes from patients with acquired immunodeficiency-like syndrome and hemphilia. The Journal of Pediatrics. 103(3). 407–410. 21 indexed citations
20.
Powars, D, et al.. (1982). Neutrophilic phagocytosis in autoimmune thrombocytopenia purpura. Journal of Pediatric Hematology/Oncology. 4(4). 375–384. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026